An Open-Label, Single-Arm, Multi-Center, Phase 2 Study of Troxatyl troxacitabine Administered by Continuous Infusion in Patients with Acute Myeloid Leukemia AML in Second Salvage

• Conditions: Patients with Acute Myeloid Leukemia AML in second salvage; MedDRA version: 9.1Level: LLTClassification code 10000880Term: Acute myeloid leukaemia

• Registration Number: EUCTR2005-001721-29-IT
• Lead Sponsor: STRUCTURAL GENOMIX

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-15
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 211

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified